A Phase II Trial of Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Bevacizumab (Primary) ; Temsirolimus (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 29 Aug 2016 Status changed from active, no longer recruiting to completed.
- 26 Jan 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Jul 2014 to 1 Jan 2016.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History